Dermelloa

Colloidal Oatmeal

Evidence types available

Human clinical trialMeta-analysis

Finely milled Avena sativa (oat) that has been FDA-approved as a skin protectant since 2003 — one of the few cosmetic ingredients with an OTC drug monograph for eczema and dry, itchy skin. Active components include avenanthramides (potent anti-inflammatory polyphenols unique to oats), beta-glucans (which form a soothing film and have immunomodulatory properties), and lipids that support barrier repair. Human clinical trials confirm reduction in itch, erythema, and TEWL in atopic dermatitis. Among the most evidence-backed options for sensitive, reactive, and eczema-prone skin. Suitable for all ages including infants. Works synergistically with ceramides and niacinamide in barrier-repair formulations.

How colloidal oatmeal works in skin

Forms protective film on skin

Physically shields and seals the barrier

Relieves itch

Avenanthramides block itch-signalling pathways

Normalises skin pH

Buffers acidic or alkaline irritants

Full cited breakdown coming soon. In the meantime the summary above reflects the current research.